Attending Physician, and M.D. in the Department of Endocrinology, Zhongda Hospital, Southeast University. Visiting Scholar at Royal Prince Alfred Hospital, Sydney, Australia. Working Secretary of the Diabetic Foot Disease Alliance under the Jiangsu Primary Endocrinology Specialty Incubation Alliance. Clinical expertise focuses on diabetic foot disease and thyroid disorders.

Marie Sinclair is a liver transplant physician whose clinical and research work focuses on sarcopenia, nutrition, obesity, and portal hypertension. She studies how body composition influences liver and non‑liver outcomes and leads multidisciplinary efforts to improve risk stratification, personalised care, and post‑transplant outcomes in cirrhosis and obesity‑related liver disease.

Elham Hosseini-Marnani is a PhD candidate at the Adelaide Medical School, University of Adelaide. Her research focuses on metabolic disorders, particularly diabetic neuropathy, obesity, and their clinical consequences. She has experience in epidemiological studies, clinical research, and systematic reviews investigating complications of type 2 diabetes.

Li Yangxi, Deputy Chief Nurse Head Nurse, Department of Endocrinology, China-Japan Friendship Hospital Director, Nursing Internal Medicine Teaching and Research Office, China-Japan Friendship Hospital Academic/Social Affiliations： Secretary, Diabetes Nursing Professional Committee, Chinese Nursing Association Youth Committee Member, Endocrinology Professional Committee, Beijing Nursing Association

Dr Harshal Deshmukh is a consultant endocrinologist in Queensland, Australia, and an Adjunct Associate Professor at James Cook University. He specialises in diabetes technology, reproductive endocrinology, and cardiometabolic disease, with extensive experience in clinical research, service development, and translational health outcomes research.

My name is Oindrila Kar and I’m a second year medical student at the University of Birmingham. Over the last year, I have developed an interest in cardiometabolic conditions through a combination of this year’s syllabus, as well as a Personal Interest Project I wrote about as a part of my course. In this, I explored some of the key risk factors and consequences of arterial thrombosis such as diabetes and hypertension, and stroke and myocardial infarction. As diabetes plays such a key role in atherosclerosis and macrovascular complications, I wanted to understand the role diabetes played in microvascular complications as well after having learned about diabetic nephropathy earlier that year. This prompted me to engage in discussions about diabetic nephropathy and ESRD and understanding the complexities around ESRD which can be seen in this paper.

Dr. Xiaohang Wang, PhD, Lecturer at Yangzhou University, Endocrinologist. Focuses on diabetes and its complications, with over 20 SCI publications.

Dr Block is a Melbourne-based Endocrinologist with clinical interests of cardiometabolic medicine and obesity management. He is undertaking a PhD in the Department of Diabetes at Monash University, supported by an NHMRC-Postgraduate Scholarship. His research focuses on developing novel RNA-based therapies to transform the treatment of diabetes and its complications.